Apg Asset Management N.V. Ironwood Pharmaceuticals Inc Transaction History

Apg Asset Management N.V.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$11.05 - $12.72 $2.08 Million - $2.39 Million	-187,800 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$10.61 - $12.88 $1.17 Million - $1.43 Million	110,700 Added 143.58%	187,800 $2.12 Million
Q4 2021 Feb 11, 2022	SELL	$10.86 - $13.95 $867,714 - $1.11 Million	-79,900 Reduced 50.89%	77,100 $791,000
Q3 2021 Nov 15, 2021	BUY	$11.92 - $13.92 $394,552 - $460,752	33,100 Added 26.72%	157,000 $1.77 Million
Q2 2021 Aug 13, 2021	BUY	$10.16 - $13.11 $1.26 Million - $1.62 Million	123,900 New	123,900 $1.35 Million

Q4 2020 Feb 12, 2021	SELL	$9.05 - $12.2 $219,010 - $295,240	-24,200 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$8.99 - $10.74 $217,558 - $259,908	24,200 New	24,200 $186,000

296

170M

27.1M

2.28M

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $999M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Apg Asset Management N.V., based on Form 13F filings with the SEC.

Stay updated on Apg Asset Management N.V. with notifications on news.